Digital Content 
NEWS #PharmaBuzz
12 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260108289260/en/FDA-Accepts-New-Drug-Application-for-Pimicotinib-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor
23 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/22/3209070/0/en/Abbisko-Therapeutics-CSF-1R-Inhibitor-Pimicotinib-Approved-by-the-China-NMPA-Addressing-the-Treatment-Gap-for-Tenosynovial-Giant-Cell-Tumor.html
23 Oct 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/clinical-trials/pimicotinib-delivers-lasting-tumor-responses-and-sustained-symptom-relief-in-tgct-patients-18060
17 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251017967416/en/Pimicotinib-Treatment-Demonstrates-Deep-and-Durable-Tumor-Responses-and-Continued-Improvements-in-Pain-and-Function-for-Patients-with-TGCT
10 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250609083793/en/Chinas-Center-for-Drug-Evaluation-Accepts-Mercks-Application-for-Marketing-Authorization-of-Pimicotinib-for-Treatment-of-Tenosynovial-Giant-Cell-Tumor
10 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-china-nmpa-acceptance-of-new-drug-application-for-pimicotinib-for-the-treatment-of-tgct-302477057.html
Share